Niagen Bioscience, Inc. (NAGE)
3.66
-0.13
(-3.43%)
USD |
NASDAQ |
May 22, 16:00
3.71
+0.05
(+1.37%)
After-Hours: 20:00
Niagen Bioscience Cash from Investing (Quarterly) : 5.245M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LifeVantage Corp. | -1.011M |
| Waldencast Plc | -- |
| The Honest Co., Inc. | -1.736M |
| CCA Industries, Inc. | 1.192M |
| Cyanotech Corp. | -0.037M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.194M |
| Cash from Financing (Quarterly) | -2.29M |
| Free Cash Flow | 4.045M |
| Free Cash Flow Per Share (Quarterly) | -0.0148 |
| Free Cash Flow to Equity (Quarterly) | -1.014M |
| Free Cash Flow to Firm (Quarterly) | -1.255M |
| Free Cash Flow Yield | 1.29% |